【摘要】：川崎病血管炎介導(dǎo)的凝血功能異常,以及冠狀動(dòng)脈內(nèi)血流動(dòng)力學(xué)變化,使冠狀動(dòng)脈內(nèi)血栓形成的風(fēng)險(xiǎn)增加。因此,川崎病抗凝治療非常重要。治療指征和療程基于冠狀動(dòng)脈嚴(yán)重程度分級(jí),所有川崎病患兒均需接受抗血小板治療,冠狀動(dòng)脈病變達(dá)到Ⅲ級(jí)者需接受兩種以上抗血小板藥物;Ⅳ級(jí)以上者需阿司匹林聯(lián)合華法林抗凝治療;合并血栓形成及心肌梗死者需及早給予溶栓治療;抗凝治療療程至少需持續(xù)3個(gè)月,如果冠狀動(dòng)脈病變持續(xù)存在需長(zhǎng)期抗凝治療。
[Abstract]:Kawasaki disease vasculitis mediates coagulation dysfunction and changes in coronary artery hemodynamics, which increases the risk of coronary thrombosis. Therefore, Kawasaki disease anticoagulant therapy is very important. The indications and course of treatment were based on the severity of coronary artery. All children with Kawasaki disease should receive antiplatelet therapy, and those with grade 鈪，

本文編號(hào)：2400187